Zhou Y - Search Results

1

Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2.

Wu S, Qi L, Chen H, Zhang K, He J, Guo X, Shen L, Zhou Y, Zhong X, Zheng S, Zhou J, Chen Y. Wu S, et al. Among authors: zhou y, zhou j. NPJ Breast Cancer. 2022 Jul 19;8(1):86. doi: 10.1038/s41523-022-00454-6. NPJ Breast Cancer. 2022. PMID: 35853885 Free PMC article.

2

Molecular hydrogen: A potential radioprotective agent.

Hu Q, Zhou Y, Wu S, Wu W, Deng Y, Shao A. Hu Q, et al. Among authors: zhou y. Biomed Pharmacother. 2020 Oct;130:110589. doi: 10.1016/j.biopha.2020.110589. Epub 2020 Aug 4. Biomed Pharmacother. 2020. PMID: 32763820 Free article. Review.

3

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance.

Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A. Yao Y, et al. Among authors: zhou y. Front Mol Biosci. 2020 Aug 20;7:193. doi: 10.3389/fmolb.2020.00193. eCollection 2020. Front Mol Biosci. 2020. PMID: 32974385 Free PMC article. Review.

4

Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition.

Guo X, Chen H, Zhou Y, Shen L, Wu S, Chen Y. Guo X, et al. Among authors: zhou y. Expert Opin Investig Drugs. 2022 Sep;31(9):933-944. doi: 10.1080/13543784.2022.2097067. Epub 2022 Jul 7. Expert Opin Investig Drugs. 2022. PMID: 35786092 Review.

5

Margetuximab: An active alternative for later-line therapy in patients with HER2-positive advanced breast cancer.

Zhou Y, Wang X, Chen Y. Zhou Y, et al. MedComm (2020). 2023 Jul 4;4(4):e322. doi: 10.1002/mco2.322. eCollection 2023 Aug. MedComm (2020). 2023. PMID: 37409110 Free PMC article. No abstract available.

6

Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study.

Zhou Y, Guo X, Shen L, Liu K, Sun Q, Wang Y, Wang H, Fu W, Yao Y, Wu S, Chen H, Qiu J, Pan T, Deng Y. Zhou Y, et al. Onco Targets Ther. 2023 Nov 16;16:939-960. doi: 10.2147/OTT.S434193. eCollection 2023. Onco Targets Ther. 2023. PMID: 38021447 Free PMC article.

7

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Arima H, Monaghan H, Joshi R, Colagiuri S, Cooper ME, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Lisheng L, Mancia G, Marre M, Matthews DR, Mogensen CE, Perkovic V, Poulter N, Rodgers A, Williams B, MacMahon S, Patel A, Woodward M; ADVANCE-ON Collaborative Group. Zoungas S, et al. N Engl J Med. 2014 Oct 9;371(15):1392-406. doi: 10.1056/NEJMoa1407963. Epub 2014 Sep 19. N Engl J Med. 2014. PMID: 25234206 Free article. Clinical Trial.

8

Ovarian metastasis from breast cancer: a comprehensive review.

Tian W, Zhou Y, Wu M, Yao Y, Deng Y. Tian W, et al. Among authors: zhou y. Clin Transl Oncol. 2019 Jul;21(7):819-827. doi: 10.1007/s12094-018-02007-5. Epub 2018 Dec 17. Clin Transl Oncol. 2019. PMID: 30560347 Review.

9

Effects of Prophylactic Administration of Granulocyte Colony-Stimulating Factor on Peripheral Leukocyte and Neutrophil Counts Levels After Chemotherapy in Patients With Early-Stage Breast Cancer: A Retrospective Cohort Study.

Tian W, Wang Y, Zhou Y, Yao Y, Deng Y. Tian W, et al. Among authors: zhou y. Front Oncol. 2022 Apr 25;12:777602. doi: 10.3389/fonc.2022.777602. eCollection 2022. Front Oncol. 2022. PMID: 35547875 Free PMC article.

10

Ovarian metastasis from breast cancer in three Chinese females: Three case reports.

Wang J, Tian W, Zhou Y, Zhang X, Deng Y. Wang J, et al. Among authors: zhou y. Medicine (Baltimore). 2019 Apr;98(17):e15395. doi: 10.1097/MD.0000000000015395. Medicine (Baltimore). 2019. PMID: 31027137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,481 results

Search Page